|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sugano K: Screening of gastric cancer in
Asia. Best Pract Res Clin Gastroenterol. 29:895–905. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gessner R and Tauber R: Intestinal cell
adhesion molecules. Liver-intestine cadherin. Ann N Y Acad Sci.
915:136–143. 2000. View Article : Google Scholar
|
|
4
|
Wendeler MW, Drenckhahn D, Gessner R and
Baumgartner W: Intestinal LI-cadherin acts as a
Ca2+-dependent adhesion switch. J Mol Biol. 370:220–230.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ito R, Oue N, Yoshida K, Kunimitsu K,
Nakayama H, Nakachi K and Yasui W: Clinicopathological significant
and prognostic influence of cadherin-17 expression in gastric
cancer. Virchows Archiv. 447:717–722. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Su MC, Yuan RH, Lin CY and Jeng YM:
Cadherin-17 is a useful diagnostic marker for adenocarcinomas of
the digestive system. Mod Pathol. 21:1379–1386. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu QF, Dong WG and Ren JL: Knockdown of
Li-cadherin increases metastatic behaviors of LoVo cells. J Cancer
Res Clin Oncol. 136:1641–1649. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Liu QS, Zhang J, Liu M and Dong WG:
Lentiviral-mediated miRNA against liver-intestine cadherin
suppresses tumor growth and invasiveness of human gastric cancer.
Cancer Sci. 101:1807–1812. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang J, Liu QS and Dong WG: Blockade of
proliferation and migration of gastric cancer via targeting CDH17
with an artificial microRNA. Med Oncol. 28:494–501. 2011.
View Article : Google Scholar
|
|
10
|
Hinoi T, Lucas PC, Kuick R, Hanash S, Cho
KR and Fearon ER: CDX2 regulates liver intestine-cadherin
expression in normal and malignant colon epithelium and intestinal
metaplasia. Gastroenterology. 123:1565–1577. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Barros R, da Costa LT, Pinto-de-Sousa J,
Duluc I, Freund JN, David L and Almeida R: CDX2 autoregulation in
human intestinal metaplasia of the stomach: Impact on the stability
of the phenotype. Gut. 60:290–298. 2011. View Article : Google Scholar :
|
|
12
|
Ge J and Chen Z, Wu S, Yuan W, Hu B and
Chen Z: A clinicopathological study on the expression of
cadherin-17 and caudal-related homeobox transcription factor (CDX2)
in human gastric carcinoma. Clin Oncol (R Coll Radiol). 20:275–283.
2008. View Article : Google Scholar
|
|
13
|
Grötzinger C, Kneifel J, Patschan D,
Schnoy N, Anagnostopoulos I, Faiss S, Tauber R, Wiedenmann B and
Gessner R: LI-cadherin: A marker of gastric metaplasia and
neoplasia. Gut. 49:73–81. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ko S, Chu KM, Luk JM, Wong BW, Yuen ST,
Leung SY and Wong J: CDX2 co-localizes with liver-intestine
cadherin in intestinal metaplasia and adenocarcinoma of the
stomach. J Pathol. 205:615–622. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cui J, Chen Y, Chou WC, Sun L, Chen L, Suo
J, Ni Z, Zhang M, Kong X, Hoffman LL, et al: An integrated
transcriptomic and computational analysis for biomarker
identification in gastric cancer. Nucleic Acids Res. 39:1197–1207.
2011. View Article : Google Scholar :
|
|
16
|
Correa P: Human gastric carcinogenesis: A
multistep and multifactorial process - First American Cancer
Society Award Lecture on Cancer Epidemiology and Prevention. Cancer
Res. 52:6735–6740. 1992.PubMed/NCBI
|
|
17
|
Yasui W, Oue N, Sentani K, Sakamoto N and
Motoshita J: Transcriptome dissection of gastric cancer:
Identification of novel diagnostic and therapeutic targets from
pathology specimens. Pathol Int. 59:121–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ko S, Chu KM, Luk JM, Wong BW, Yuen ST,
Leung SY and Wong J: Overexpression of LI-cadherin in gastric
cancer is associated with lymph node metastasis. Biochem Biophys
Res Commun. 319:562–568. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang J, Yu JC, Kang WM, Wang WZ, Liu YQ
and Gu P: The predictive effect of cadherin-17 on lymph node
micrometastasis in pN0 gastric cancer. Ann Surg Oncol.
19:1529–1534. 2012. View Article : Google Scholar
|
|
20
|
Xu Y, Zhang J, Liu QS and Dong WG:
Knockdown of liver-intestine cadherin decreases BGC823 cell
invasiveness and metastasis in vivo. World J Gastroenterol.
18:3129–3137. 2012. View Article : Google Scholar PubMed/NCBI
|
|
21
|
Wu WK, Cho CH, Lee CW, Fan D, Wu K, Yu J
and Sung JJ: Dysregulation of cellular signaling in gastric cancer.
Cancer Lett. 295:144–153. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Song Y, Dong MM and Yang HF: Effects of
RNA interference targeting four different genes on the growth and
proliferation of nasopharyngeal carcinoma CNE-2Z cells. Cancer Gene
Ther. 18:297–304. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liu LX, Lee NP, Chan VW, Xue W, Zender L,
Zhang C, Mao M, Dai H, Wang XL, Xu MZ, et al: Targeting cadherin-17
inactivates Wnt signaling and inhibits tumor growth in liver
carcinoma. Hepatology. 50:1453–1463. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kwak JM, Min BW, Lee JH, Choi JS, Lee SI,
Park SS, Kim J, Um JW, Kim SH and Moon HY: The prognostic
significance of E-cadherin and liver intestine-cadherin expression
in colorectal cancer. Dis Colon Rectum. 50:1873–1880. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Takamura M, Ichida T, Matsuda Y, Kobayashi
M, Yamagiwa S, Genda T, Shioji K, Hashimoto S, Nomoto M, Hatakeyama
K, et al: Reduced expression of liver-intestine cadherin is
associated with progression and lymph node metastasis of human
colorectal carcinoma. Cancer Lett. 212:253–259. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tait SW and Green DR: Mitochondria and
cell death: Outer membrane permeabilization and beyond. Nat Rev Mol
Cell Biol. 11:621–632. 2010. View
Article : Google Scholar : PubMed/NCBI
|
